STOCK TITAN

[Form 4] ClearPoint Neuro, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

ClearPoint Neuro (CLPT) disclosed a Form 4 for its Chief Operating Officer, Mazin Sabra. On 10/10/2025, 7,480 shares of common stock were withheld (Transaction Code F) to satisfy tax obligations upon the vesting of restricted stock at $26.11 per share. After the transaction, the reporting person beneficially owns 44,084 shares, held directly.

ClearPoint Neuro (CLPT) ha divulgato un Form 4 per il suo Chief Operating Officer, Mazin Sabra. Il 10/10/2025, sono state trattenute 7,480 azioni ordinarie (Codice di Transazione F) per soddisfare gli obblighi fiscali al vesting delle azioni escluse a $26.11 per azione. Dopo la transazione, la persona che riferisce detiene direttamente 44,084 azioni.

ClearPoint Neuro (CLPT) reveló un Form 4 para su Director de Operaciones, Mazin Sabra. El 10/10/2025, se retuvieron 7,480 acciones ordinarias (Código de Transacción F) para satisfacer las obligaciones fiscales al vesting de las acciones restringidas a $26.11 por acción. Después de la transacción, la persona informante posee 44,084 acciones directamente.

ClearPoint Neuro (CLPT)은 최고운영책임자 Mazin Sabra를 위한 Form 4를 공개했습니다. 2025년 10월 10일, 보통주 7,480주가 거래 코드 F에 따라 보류되어 제한 주식의 vesting에 따른 세금 의무를 충당했습니다. 주당 $26.11로. 거래 이후 보고자는 44,084주를 직접 보유합니다.

ClearPoint Neuro (CLPT) a divulgué un Form 4 pour son directeur des opérations, Mazin Sabra. Le 10/10/2025, 7 480 actions ordinaires ont été retenues (Code de transaction F) pour satisfaire les obligations fiscales lors du vesting des actions restreintes à $26,11 par action. Après la transaction, la personne déclarant détient directement 44 084 actions.

ClearPoint Neuro (CLPT) hat einen Form 4 für seinen Chief Operating Officer Mazin Sabra offengelegt. Am 10.10.2025 wurden 7.480 Aktien Stammaktien gemäß Transaktionscode F einbehalten, um Steuerverpflichtungen aufgrund des Vestings der Restricted Stock zu erfüllen, zu einem Preis von $26,11 pro Aktie. Nach der Transaktion besitzt die meldende Person direkt 44.084 Aktien.

أفصحت ClearPoint Neuro (CLPT) عن نموذج 4 لمسؤولها التنفيذي للعمليات، مازن صبرا. في 10/10/2025، تم حجز 7,480 سهماً عادياً (رمز الصفقة F) لتلبية الالتزامات الضريبية عند استحقاق الأسهم المقيدة بسعر $26.11 للسهم. بعد الصفقة، يمتلك الشخص المبلغ عنه 44,084 سهماً بشكل مباشر.

ClearPoint Neuro (CLPT) 披露了其首席运营官 Mazin Sabra 的 Form 4。2025年10月10日,7,480 股普通股被扣留(交易代码 F),以在受限股归属时履行税务义务,股价为每股 $26.11。交易后,上报人直接持有 44,084 股

Positive
  • None.
Negative
  • None.

ClearPoint Neuro (CLPT) ha divulgato un Form 4 per il suo Chief Operating Officer, Mazin Sabra. Il 10/10/2025, sono state trattenute 7,480 azioni ordinarie (Codice di Transazione F) per soddisfare gli obblighi fiscali al vesting delle azioni escluse a $26.11 per azione. Dopo la transazione, la persona che riferisce detiene direttamente 44,084 azioni.

ClearPoint Neuro (CLPT) reveló un Form 4 para su Director de Operaciones, Mazin Sabra. El 10/10/2025, se retuvieron 7,480 acciones ordinarias (Código de Transacción F) para satisfacer las obligaciones fiscales al vesting de las acciones restringidas a $26.11 por acción. Después de la transacción, la persona informante posee 44,084 acciones directamente.

ClearPoint Neuro (CLPT)은 최고운영책임자 Mazin Sabra를 위한 Form 4를 공개했습니다. 2025년 10월 10일, 보통주 7,480주가 거래 코드 F에 따라 보류되어 제한 주식의 vesting에 따른 세금 의무를 충당했습니다. 주당 $26.11로. 거래 이후 보고자는 44,084주를 직접 보유합니다.

ClearPoint Neuro (CLPT) a divulgué un Form 4 pour son directeur des opérations, Mazin Sabra. Le 10/10/2025, 7 480 actions ordinaires ont été retenues (Code de transaction F) pour satisfaire les obligations fiscales lors du vesting des actions restreintes à $26,11 par action. Après la transaction, la personne déclarant détient directement 44 084 actions.

ClearPoint Neuro (CLPT) hat einen Form 4 für seinen Chief Operating Officer Mazin Sabra offengelegt. Am 10.10.2025 wurden 7.480 Aktien Stammaktien gemäß Transaktionscode F einbehalten, um Steuerverpflichtungen aufgrund des Vestings der Restricted Stock zu erfüllen, zu einem Preis von $26,11 pro Aktie. Nach der Transaktion besitzt die meldende Person direkt 44.084 Aktien.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
SABRA MAZIN

(Last) (First) (Middle)
C/O CLEARPOINT NEURO, INC.
120 S SIERRA AVE., SUITE 100

(Street)
SOLANA BEACH CA 92075

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ClearPoint Neuro, Inc. [ CLPT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/10/2025 F 7,480(1) D $26.11 44,084 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.
/s/ Danilo D'Alessandro, by Power of Attorney for Mazin Sabra 10/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CLPT disclose in this Form 4?

The COO reported a tax-withholding transaction tied to restricted stock vesting, with 7,480 shares withheld at $26.11 (Code F).

How many shares were involved and at what price?

7,480 shares were withheld at $26.11 per share.

Why were the shares withheld?

To satisfy tax withholding obligations upon the vesting of restricted stock.

Who is the reporting person and role at CLPT?

Mazin Sabra, Chief Operating Officer.

How many shares does the insider own after the transaction?

44,084 shares, held directly.

When did the transaction occur?

10/10/2025.

What was the SEC transaction code?

F (payment of tax liability by withholding securities).

Clearpoint Neuro Inc

NASDAQ:CLPT

CLPT Rankings

CLPT Latest News

CLPT Latest SEC Filings

CLPT Stock Data

718.65M
26.05M
8.19%
38.99%
8.25%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SOLANA BEACH